Management ChangeJun 5, 2026, 06:36 AM
Basel Medical Appoints Neo Chun How Alton as Interim CFO
AI Summary
Basel Medical Group Ltd announced the appointment of Mr. Neo Chun How Alton as its new interim Chief Financial Officer, effective June 2, 2026. Mr. Neo replaces Ms. Jianing Lu, who resigned from the position. Mr. Neo brings extensive experience in corporate leadership and financial management, having previously served as deputy CEO of InCorp Global's Singapore operations.
Key Highlights
- Basel Medical Group Ltd appointed Mr. Neo Chun How Alton as its new interim Chief Financial Officer.
- The appointment is effective June 2, 2026.
- Mr. Neo replaces Ms. Jianing Lu, who resigned from the CFO position.
- Mr. Neo previously served as deputy CEO of InCorp Global's Singapore operations.
- His expertise includes management reporting, corporate restructuring, business valuation, insolvency, and forensic accounting.
- Mr. Neo holds an MBA and is a Chartered Valuer, CA Singapore, and CPA Australia.
Price Impact
More from BMGL